昼夜节律在脂肪性肝病发病与治疗中的作用
本文综述昼夜节律蛋白在NAFLD发病与治疗中的作用。中枢与外周节律失协调是代谢综合征和NAFLD模型的核心特征,限时进食可同步节律并防治肝脂肪变,多种NAFLD药物靶点受节律蛋白调控,生物钟本身可作治疗靶点。
要点
- 中枢与外周昼夜节律失协调是NAFLD的核心特征之一
- 限时进食可同步节律,预防甚至治疗代谢综合征与肝脂肪变
- SREBP、ACC、PPARs和肠促胰岛素等NAFLD靶点受节律蛋白调控
核心结论
- 昼夜节律失协调参与NAFLD发病,同步节律或靶向生物钟可用于防治NAFLD。
研究设计与样本
- 本文为综述,汇总昼夜节律在脂肪性肝病发病与治疗中的相关研究。
主要发现
- 中枢与外周昼夜节律失协调是几乎所有遗传、饮食或环境代谢综合征与NAFLD模型的核心特征。
- 将进食限制在每日固定时间窗内可同步中枢与外周节律,从而预防甚至治疗代谢综合征和肝脂肪变。
- SREBP、ACC、PPARs和肠促胰岛素等正在研究的NAFLD药物靶点受昼夜节律蛋白调控。
临床怎么用
- 可利用生物钟优化NAFLD药物的获益并减少不良反应。
- 昼夜节律本身可作为NAFLD的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circadian clock proteins are endogenous timing mechanisms that control the transcription of hundreds of genes. Their integral role in coordinating metabolism has led to their scrutiny in a number of diseases, including nonalcoholic fatty liver disease (NAFLD). Discoordination between central and peripheral circadian rhythms is a core feature of nearly every genetic, dietary, or environmental model of metabolic syndrome and NAFLD. Restricting feeding to a defined daily interval (time-restricted feeding) can synchronize the central and peripheral circadian rhythms, which in turn can prevent or even treat the metabolic syndrome and hepatic steatosis. Importantly, a number of proteins currently under study as drug targets in NAFLD (sterol regulatory element-binding protein [SREBP], acetyl-CoA carboxylase [ACC], peroxisome proliferator-activator receptors [PPARs], and incretins) are modulated by circadian proteins. Thus, the clock can be used to maximize the benefits and minimize the adverse effects of pharmaceutical agents for NAFLD. The circadian clock itself has the potential for use as a target for the treatment of NAFLD.
引用
- Saran AR, Dave S, Zarrinpar A, et al. Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease. Gastroenterology. 2020. PMID: 32061597. doi:10.1053/j.gastro.2020.01.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。